NasdaqGS - Nasdaq Real Time Price USD
Immunovant, Inc. (IMVT)
14.75
+0.30
+(2.08%)
As of 12:20:20 PM EDT. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-324,936
-214,227
-188,193
-106,112
-83,327
Investing Cash Flow
-708
-360
-197
-254
-210
Financing Cash Flow
5,425
472,427
70,885
200,129
383,112
End Cash Position
370,718
635,365
376,532
493,817
400,146
Income Tax Paid Supplemental Data
810
509
--
--
166
Capital Expenditure
-708
-360
-197
-254
-210
Issuance of Capital Stock
--
472,745
70,500
--
319,783
Repayment of Debt
--
--
--
--
-3,190
Free Cash Flow
-325,644
-214,587
-188,390
-106,366
-83,537
3/31/2021 - 6/21/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ROIV Roivant Sciences Ltd.
10.90
+1.44%
CYTK Cytokinetics, Incorporated
40.37
+6.24%
SRRK Scholar Rock Holding Corporation
33.32
+2.46%
SWTX SpringWorks Therapeutics, Inc.
41.97
+1.84%
ARGX argenx SE
604.49
+1.65%
BBIO BridgeBio Pharma, Inc.
35.83
+1.70%
LXEO Lexeo Therapeutics, Inc.
3.4800
+3.26%
MTSR Metsera, Inc.
20.17
-14.46%
MRUS Merus N.V.
43.52
+4.04%
MLTX MoonLake Immunotherapeutics
39.54
+0.08%